Market revenue in 2023 | USD 79.8 million |
Market revenue in 2030 | USD 113.5 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Total laparoscopic hysterectomy (tlh) |
Fastest growing segment | Laparoscopic Supracervical Hysterectomy (LSH) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Total Laparoscopic Hysterectomy (TLH), Laparoscopic Supracervical Hysterectomy (LSH), Laparoscopically Assisted Vaginal Hysterectomy (LAVH), Sacrocolpopexy |
Key market players worldwide | Johnson & Johnson, The Cooper Companies Inc, B. Braun Medical, Karl Storz, Conmed Corp, RUDOLF Medical, LiNA, Richard Wolf, Utah Medical Products Inc, PURPLE SURGICAL MANUFACTURING LIMITED, Conkin Surgical Instruments, Laborie Medical Technologies, Bissinger, The O.R. Company, LSI Solutions |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to uterine manipulation devices market will help companies and investors design strategic landscapes.
Total laparoscopic hysterectomy (tlh) was the largest segment with a revenue share of 38.35% in 2023. Horizon Databook has segmented the U.S. uterine manipulation devices market based on total laparoscopic hysterectomy (tlh), laparoscopic supracervical hysterectomy (lsh), laparoscopically assisted vaginal hysterectomy (lavh), sacrocolpopexy covering the revenue growth of each sub-segment from 2018 to 2030.
The growing awareness about the benefits of minimally invasive surgeries and laparoscopic procedures is one of the major factors expected to aid market growth. In addition, the increasing prevalence of uterine cancer and uterine fibroids is predicted to drive market growth in the U.S. over the forecast period.
According to the American Cancer Society, around 67,880 new cases of uterus cancer are expected to be diagnosed by the end of 2024. In the U.S., uterine fibroids are responsible for 39.0% of all hysterectomies performed annually, making them the leading indications for hysterectomy. For instance, according to the CDC, over 600,000 hysterectomies (surgical removal of the uterus) are performed annually.
Moreover, according to the International Agency for Research on Cancer, in 2022, about 13,920 cervical cancer cases were reported in the U.S. In 2021, the percentage of women who received hysterectomy increased with age, from 2.8% for women ages 18–44 to 22.1% for women ages 45–64; around 35.0% for women of ages 65–74; and 41.8% for women aged 75 and older. Furthermore, the growing cases of cervical cancer are another major factor anticipated to fuel market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. uterine manipulation devices market , including forecasts for subscribers. This country databook contains high-level insights into U.S. uterine manipulation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account